Revisión sistemática

Published on 3 de marzo de 2021 | http://doi.org/10.5867/medwave.2021.02.8105

Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials

Back to article Figure 1.

PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) Flowchart.